[ad_1]
The UK has approved the Pfizer pill to fight Covid-19 in patients over the age of 18.
The approval of this drug came at a time when the country marked a record number of new cases with Covid-19.
The data show that the Paxlovid pill is most effective when the patient takes it in the early stages of infection. According to the British regulator of medicines and health care, the drug should be used the first five days after the onset of symptoms.
The Pfizer company this month stated that Paxlovid is nearly 90 percent effective in preventing hospitalization. And according to the latest data, this drug is just as effective against the new version of the rapidly spreading coronavirus, Omicron.
“We now have another antiviral drug for the treatment of Covid-19, which can be taken orally instead of intravenously. This means that this medicine can also be used at home, on the recommendation of a family doctor“, Said in a statement to the media, the head of the British drug regulator, June Raine.
One month ago, Pfizer announced that it had applied to the US Food and Drug Administration for approval of the urgent use of Covid-19 in pill form. Pfizer announced on November 5 that the PAXLOVID pill reduces the risk of hospitalization or death from the effects of the coronavirus by 90 percent.
Previously, all FDA-approved COVID-19 treatments required intravenous injection under the supervision of healthcare professionals in hospitals and clinics.
top channel
[ad_2]
Source link
